What does Dr. Tim Wessels – Algemene Medische Oncologie do?

Dr. Tim Wessels – Algemene Medische Oncologie is a specialist medical practice in Holsbeek. Private Limited, started on 5 July 2020, 1 establishment.

What is the address of Dr. Tim Wessels – Algemene Medische Oncologie?

The registered office of Dr. Tim Wessels – Algemene Medische Oncologie is located at Sint-Geertruibos 23, 3220 Holsbeek.

Is Dr. Tim Wessels – Algemene Medische Oncologie still active?

Yes. According to the CBE (15 November 2026) Dr. Tim Wessels – Algemene Medische Oncologie is active, legal situation “Normale toestand”, started on 5 July 2020.

Is Dr. Tim Wessels – Algemene Medische Oncologie registered on Peppol?

Yes, Dr. Tim Wessels – Algemene Medische Oncologie is registered on the Peppol network with ID 0208:0749800694.

What is the enterprise number of Dr. Tim Wessels – Algemene Medische Oncologie?

The enterprise number of Dr. Tim Wessels – Algemene Medische Oncologie is BE0749800694.

When was Dr. Tim Wessels – Algemene Medische Oncologie founded?

Dr. Tim Wessels – Algemene Medische Oncologie was founded on 5 July 2020.

Is Dr. Tim Wessels – Algemene Medische Oncologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 July 2020; 5 annual accounts filed, latest fiscal year 2025; 1 events from the Belgian Official Gazette processed.

How much profit did Dr. Tim Wessels – Algemene Medische Oncologie make in 2025?

Dr. Tim Wessels – Algemene Medische Oncologie posted a profit after taxes of € 235,964 in financial year 2025.

What is the revenue of Dr. Tim Wessels – Algemene Medische Oncologie?

As a small company, Dr. Tim Wessels – Algemene Medische Oncologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 314,568.

Dr. Tim Wessels – Algemene Medische Oncologie (Private Limited)

Dossier Dr. Tim Wessels – Algemene Medische Oncologie, printed on 15 November 2026 from databakkes.be/en/0749800694/dr-tim-wessels-algemene-medische-oncologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Tim Wessels – Algemene Medische Oncologie from Holsbeek, company number BE0749800694, closed financial year 2025 with a result of € 235,964 after tax. For that financial year Dr. Tim Wessels – Algemene Medische Oncologie recorded a gross margin of € 314,568 and equity of € 18,430. Compared with financial year 2024, the result moved from € 198,988 to € 235,964. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 5, 2026.

What it is worth Growing

€ 18,430

▲ 48% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 235,964

▲ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 233,134

▲ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 230,000 paid out

97 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 168

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 4,999

▼ 15% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,640

▼ 19% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 14,481

▼ 43% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 119,454 Gross margin 2022: € 119,454 First fiscal year in the series	€ 189,012 Gross margin 2023: € 189,012 ▲ 58% vs 2022 (€ 119,454) Favourable step	€ 271,643 Gross margin 2024: € 271,643 ▲ 44% vs 2023 (€ 189,012) Favourable step	€ 314,568 Gross margin 2025: € 314,568 ▲ 16% vs 2024 (€ 271,643) Favourable step	▲ 16%
Profit after taxes	€ 90,947 Profit after taxes 2022: € 90,947 First fiscal year in the series	€ 144,595 Profit after taxes 2023: € 144,595 ▲ 59% vs 2022 (€ 90,947) Favourable step	€ 198,988 Profit after taxes 2024: € 198,988 ▲ 38% vs 2023 (€ 144,595) Favourable step	€ 235,964 Profit after taxes 2025: € 235,964 ▲ 19% vs 2024 (€ 198,988) Favourable step	▲ 19%
Equity	€ 160,882 Equity 2022: € 160,882 First fiscal year in the series	€ 305,478 Equity 2023: € 305,478 ▲ 90% vs 2022 (€ 160,882) Favourable step	€ 12,466 Equity 2024: € 12,466 ▼ 96% vs 2023 (€ 305,478) Unfavourable step	€ 18,430 Equity 2025: € 18,430 ▲ 48% vs 2024 (€ 12,466) Favourable step	▲ 48%
Total debts	€ 45,098 Total debts 2022: € 45,098 First fiscal year in the series	€ 45,518 Total debts 2023: € 45,518 ▲ 1% vs 2022 (€ 45,098) Unfavourable step	€ 217,383 Total debts 2024: € 217,383 ▲ € 171,865 vs 2023 (€ 45,518) Unfavourable step	€ 244,121 Total debts 2025: € 244,121 ▲ 12% vs 2024 (€ 217,383) Unfavourable step	▲ 12%
Cash	€ 203,686 Cash 2022: € 203,686 First fiscal year in the series	€ 345,594 Cash 2023: € 345,594 ▲ 70% vs 2022 (€ 203,686) Favourable step	€ 204,224 Cash 2024: € 204,224 ▼ 41% vs 2023 (€ 345,594) Unfavourable step	€ 233,134 Cash 2025: € 233,134 ▲ 14% vs 2024 (€ 204,224) Favourable step	▲ 14%
Land & buildings	-	-	€ 2,537 Land & buildings 2024: € 2,537 First fiscal year in the series	-
Retained profit	€ 157,882 Retained profit 2022: € 157,882 First fiscal year in the series	€ 302,478 Retained profit 2023: € 302,478 ▲ 92% vs 2022 (€ 157,882) Favourable step	€ 9,466 Retained profit 2024: € 9,466 ▼ 97% vs 2023 (€ 302,478) Unfavourable step	€ 15,430 Retained profit 2025: € 15,430 ▲ 63% vs 2024 (€ 9,466) Favourable step	▲ 63%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 492,000 Dividend 2024: € 492,000 Unchanged (€ 0) Unchanged	€ 230,000 Dividend 2025: € 230,000 ▼ 53% vs 2024 (€ 492,000) Unchanged	▼ 53%
Balance sheet total	€ 205,980 Balance sheet total 2022: € 205,980 First fiscal year in the series	€ 350,996 Balance sheet total 2023: € 350,996 ▲ 70% vs 2022 (€ 205,980) Unchanged	€ 229,849 Balance sheet total 2024: € 229,849 ▼ 35% vs 2023 (€ 350,996) Unchanged	€ 262,551 Balance sheet total 2025: € 262,551 ▲ 14% vs 2024 (€ 229,849) Unchanged	▲ 14%

By gross margin, Dr. Tim Wessels – Algemene Medische Oncologie ranks 5th of 11 companies with main activity “Activiteiten van medisch specialisten” in Holsbeek that publish figures (fiscal year 2025).

Key figures of Dr. Tim Wessels – Algemene Medische Oncologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about Dr. Tim Wessels – Algemene Medische Oncologie the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to Dr. Tim Wessels – Algemene Medische Oncologie?

What happened at Dr. Tim Wessels – Algemene Medische Oncologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 5, 2026 New annual accounts for financial year 2025: profit of € 235,964 (▲ 19% vs 2024). filed late Source: NBB ↗
Jul 8, 2020 Incorporation, published in the Gazette. Source: Staatsblad ↗
Jul 5, 2020 New establishment in Holsbeek. KBO